Statements of Cash Flows - USD ($)	12 Months Ended
	Nov. 30, 2023	Nov. 30, 2022
Cash flows from operating activities:
Net income	$ 3,673,548	$ 906,058
Adjustments to reconcile net loss to net cash used in operating activities:
Interest earned on marketable securities held in Trust Account	(5,016,986)	(1,326,563)
Changes in operating assets and liabilities:
Prepaid expenses	66,692	(111,669)
Accounts payable	86,351	8,789
Accrued expenses	386,100	7,500
Net cash used in operating activities	(804,295)	(515,885)
Cash flows from investing activities:
Cash withdrawn from Trust Account in connection with redemption	43,058,659
Investment of cash in Trust Account	(2,940,000)	(116,725,000)
Net cash used in investing activities	40,118,659	(116,725,000)
Cash flows from financing activities:
Redemption of ordinary shares	(43,058,659)
Proceeds from working capital loan	650,000
Proceeds from extension loan	2,940,000
Collection of subscription receivable		25,000
Proceeds from sale of Units, net of IPO costs		112,366,519
Proceeds from sale of private placement units		5,325,000
Repayment of promissory note – related party		(174,406)
Net cash provided by financing activities	(39,468,659)	117,542,113
Net change in cash	(154,295)	301,228
Cash at the beginning of the period	301,228
Cash at the end of the period	146,933	301,228
Supplemental disclosure of non-cash investing and financing activities:
Remeasurement of Common Stock subject to redemption	5,016,986
Extension Funds attributable to Common Stock subject to redemption	2,940,000
Deferred underwriting fee payable		4,025,000
Initial Classification of Class A ordinary shares subject to redemption		118,051,563
Deferred offering costs paid for by Promissory note – related party		$ 68,411